Magellan Group

Magellan BioScience Group is an innovative drug discovery company focused on identifying novel lead candidates derived from untapped sources of chemical diversity, particularly microorganisms from marine and other biodiverse environments. The company utilizes a proprietary production and screening platform to develop libraries of natural products and synthetic peptides for pharmaceutical and industrial applications. Its primary research efforts target high-impact areas such as multi-drug resistant infectious diseases (including MRSA and VRSA), oncology, and inflammation. By leveraging its extensive collection of microbial strains and specialized chemical libraries, Magellan BioScience Group aims to accelerate the development of new chemical entities through strategic partnerships with pharmaceutical and biotechnology firms.